This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Understand what your retirement savings goal should be at 30. Ensure a secure financial future with proper planning.
24,773 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
The Stanford board sold HeartFlow shares for about $8.5 million, triggering questions about insider signals. This art...
When a fund trims its Planet Fitness position, it sends a message about risk, growth, and the path for 2026. This dee...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...
The Macy's 2026 earnings call will reveal how a storied department store navigates digital growth, store productivity...
Marvell is signaling rapid growth in its custom chips for AI accelerators. This article breaks down the forecast, wha...
A domestic uranium producer is expanding beyond ore to processing key minerals. This article breaks down the strategy...
Hyperliquid just crossed a dramatic milestone: hyperliquid generated billion revenue across its protocol in under two...
An executive chair's sizable stock sale draws attention. This piece explains what the numbers mean, how to read insid...
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
As Life360 maps its path into 2025, investors face a pivotal question: will the life360 (lif) 2025 earnings story hin...
A fresh look at how to read Lifetime Brands' Q4 2025 earnings transcript. This guide explains key metrics, growth dri...